Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports

2015158 citationsReviewhybrid Open Access

Authors

Jennita Reefhuis · Centers for Disease Control and Prevention

Owen Devine · National Center on Birth Defects and Developmental Disabilities

Jan M. Friedman · University of British Columbia

Margaret A. Honein · National Center on Birth Defects and Developmental Disabilities

Abstract

These data provide reassuring evidence for some SSRIs but suggest that some birth defects occur 2-3.5 times more frequently among the infants of women treated with paroxetine or fluoxetine early in pregnancy.

Topics & Keywords

Birth, Development, and Health Maternal Mental Health During Pregnancy and Postpartum Pregnancy and preeclampsia studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMJ

Volume 351, pp. h3190-h3190

DOI: 10.1136/bmj.h3190

Field-Weighted Citation Impact: 44.19